Clicky

PerkinElmer, Inc.(PKI)

Description: PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, research, environmental, industrial, and laboratory services markets worldwide. The company operates in two segments, Human Health and Environmental Health. The Human Health segment develops diagnostics, tools, and applications to help detect diseases earlier, as well as accelerate the discovery and development of critical new therapies. This segment provides early detection for genetic disorders from pre-conception to early childhood, as well as digital x-ray flat panel detectors and infectious disease testing for the diagnostics market. It also provides a suite of solutions, including reagents, liquid handling, and detection and imaging technologies that enable researchers to improve the drug discovery process. This segment's research portfolio comprises instrumentation for automation and detection solutions, in vitro and in vivo imaging and analysis hardware and software, and a portfolio of consumable products, such as drug discovery and research reagents. The Environmental Health segment offers technologies and applications to facilitate the creation of safer food and consumer products, secure surroundings, and efficient energy resources. This segment provides analytical technologies that address the quality of environment, sustainable energy development, and ensure safer food and consumer products; analytical instrumentation for the industrial market, which includes the semiconductor, chemical, petrochemical, lubricant, construction, office equipment, and quality assurance industries; and laboratory services. The company markets its products and services directly through its own sales forces. Its customers include pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. The company was founded in 1931 and is headquartered in Waltham, Massachusetts.


Keywords: Chemical Biotechnology Semiconductor S&P 500 Disease Consumer Products Tools Imaging Infectious Diseases Drug Discovery X Ray Office Equipment Public Health Energy Development Sustainable Energy Mental Health Laboratory Services Quality Assurance Energy Resources In Vitro Detectors Consumable Products Healthcare Organizations Childhood Lab Testing Genetic Disorder Radiometer Diagnostics Imaging Technologies Detection Solutions Analytical Technologies

Home Page: www.perkinelmer.com

PKI Technical Analysis

940 Winter Street
Waltham, MA 02451
United States
Phone: 781 663 6900


Officers

Name Title
Dr. Prahlad R. Singh Ph.D. CEO, Pres & Director
Mr. Tajinder Vohra Sr. VP of Global Operations
Mr. Joel S. Goldberg Sr. VP of Admin., Gen. Counsel & Sec.
Mr. Daniel R. Tereau Sr. VP of Strategy & Bus. Devel.
Mr. Maxwell Krakowiak Sr. VP & CFO
Mr. Andrew Okun VP, Chief Accounting Officer & Treasurer
Mr. Stephen Barr Willoughby Sr. VP of Investor Relations & Head of ESG
Mr. Robert Francis Friel Advisor
Ms. Miriame Victor Sr. VP & Chief Commercial Officer
Dr. Masoud Toloue Ph.D. Sr. VP of Diagnostics

Exchange: NYSE

Country: US : United States of America

Currency: US Dollar ($)

Forward PE: 22.5225
Trailing PE: 25.7294
Price-to-Book MRQ: 2.5693
Price-to-Sales TTM: 3.6825
IPO Date: 1983-04-06
Fiscal Year End: December
Full Time Employees: 16000
Back to stocks